These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4479763)

  • 1. Oral hypoglycemic agents: 1-(2-carboxyphenyl)pyrroles.
    Sugihara H; Matsumoto N; Hamuro Y; Kawamatsu Y
    Arzneimittelforschung; 1974 Oct; 24(10):1560-3. PubMed ID: 4479763
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pyrrolic derivatives with hypoglycemic activity].
    Lotti B; Vezzosi O
    Farmaco Sci; 1972 Apr; 27(4):317-21. PubMed ID: 5024001
    [No Abstract]   [Full Text] [Related]  

  • 3. Substituted tetrahydropyrrolo[2,1-b]oxazol-5(6H)-ones and tetrahydropyrrolo[2,1-b]thiazol-5(6H)-ones as hypoglycemic agents.
    Aicher TD; Balkan B; Bell PA; Brand LJ; Cheon SH; Deems RO; Fell JB; Fillers WS; Fraser JD; Gao J; Knorr DC; Kahle GG; Leone CL; Nadelson J; Simpson R; Smith HC
    J Med Chem; 1998 Nov; 41(23):4556-66. PubMed ID: 9804695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology of HB 419, a new strongly effective oral antidiabetic].
    Bänder A; Pfaff W; Schmidt FH; Stork H; Schröder HG
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1363-8. PubMed ID: 5394454
    [No Abstract]   [Full Text] [Related]  

  • 5. 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivatives.
    Hall A; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Hammond B; Healy MP; Johnson MR; Metcalf A; Michel AD; Naylor A; Novelli R; Spalding DJ; Sweeting J
    Bioorg Med Chem Lett; 2007 Feb; 17(3):732-5. PubMed ID: 17098427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic prodrugs of 4-(2,2-dimethyl-1-oxopropyl)benzoic acid.
    Aicher TD; Bebernitz GR; Bell PA; Brand LJ; Dain JG; Deems R; Fillers WS; Foley JE; Knorr DC; Nadelson J; Otero DA; Simpson R; Strohschein RJ; Young DA
    J Med Chem; 1999 Jan; 42(1):153-63. PubMed ID: 9888840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mercaptopyridinecarboxylic acids, synthesis and hypoglycemic activity.
    Blank B; DiTullio NW; Miao CK; Owings FF; Gleason JG; Ross ST; Berkoff CE; Saunders HL
    J Med Chem; 1974 Oct; 17(10):1065-71. PubMed ID: 4417798
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of tolbutamide and HB 419 on blood glucose, plasma-corticosterone and liver glycogen in rats].
    Hasselblatt A; Panten U; Poser W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1483-7. PubMed ID: 5394471
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acylaminoalkylbenzolsulfonylureas].
    Weber H; Aumüller W; Muth K; Weyer R; Heerdt R; Fauland E; Bänder A; Pfaff W; Schmidt FH; Stork H
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1326-46. PubMed ID: 5394451
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclization of lactamimide ketones to imidazo(1,2-a)-azacycloalkanes with hypoglycemic activity.
    Claxton GP; Grisar JM; Wiech NL
    J Med Chem; 1974 Mar; 17(3):364-7. PubMed ID: 4811238
    [No Abstract]   [Full Text] [Related]  

  • 11. New oral antidiabetic drugs. 3.
    Ambrogi V; Bloch K; Daturi S; Logemann W; Parenti MA; Tommasini R
    Arzneimittelforschung; 1972 Mar; 22(3):542-4. PubMed ID: 5067927
    [No Abstract]   [Full Text] [Related]  

  • 12. [New hypoglycemic benzenesulfonamido-pyrimidines N-substituted 4- N-(2-pyrimidinyl) sulfonyl--phenylacetamides].
    Gutsche K; Schröder E; Rufer C; Loge O
    Arzneimittelforschung; 1974 Jul; 24(7):1028-39. PubMed ID: 4408077
    [No Abstract]   [Full Text] [Related]  

  • 13. Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase.
    Hoover DJ; Lefkowitz-Snow S; Burgess-Henry JL; Martin WH; Armento SJ; Stock IA; McPherson RK; Genereux PE; Gibbs EM; Treadway JL
    J Med Chem; 1998 Jul; 41(16):2934-8. PubMed ID: 9685232
    [No Abstract]   [Full Text] [Related]  

  • 14. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
    Brzozowski Z; Wójcikowski C
    Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Derivatives of sulfamoyl-aryloxyalkyl carboxylic acids with hypoglycemic action].
    Braha S; Oniscu C; Simionovici M
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):316-20. PubMed ID: 4089334
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoglycaemic activity and structure activity relationship of a new series of sulphonylurea derivatives.
    Gandhi TP; Jindal MN
    Arzneimittelforschung; 1971 Jul; 21(7):968-71. PubMed ID: 5109511
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acylaminoalkylbenzolsulfonylaminopyrimidines as blood sugar decreasing substances].
    Heerdt R; Hübner M; Fauland E; Hagedorn A; Weber H; Aumüller W; Muth K; Weyer R; Schmidt FH; Stork H
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1346-50. PubMed ID: 5394452
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and evaluation of novel spiro derivatives for pyrrolopyrimidines as anti-hyperglycemia promising compounds.
    Fatahala SS; Mahgub S; Taha H; Abd-El Hameed RH
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):809-817. PubMed ID: 29708461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives.
    Hall A; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Hammond B; Healy MP; Johnson MR; Metcalf A; Michel AD; Naylor A; Novelli R; Spalding DJ; Sweeting J; Winyard L
    Bioorg Med Chem Lett; 2007 Feb; 17(4):916-20. PubMed ID: 17175160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
    Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
    Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.